Cor Lieftink

6.0k total citations
48 papers, 1.7k citations indexed

About

Cor Lieftink is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Cor Lieftink has authored 48 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 16 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Cor Lieftink's work include CRISPR and Genetic Engineering (8 papers), Cancer-related Molecular Pathways (8 papers) and DNA Repair Mechanisms (7 papers). Cor Lieftink is often cited by papers focused on CRISPR and Genetic Engineering (8 papers), Cancer-related Molecular Pathways (8 papers) and DNA Repair Mechanisms (7 papers). Cor Lieftink collaborates with scholars based in Netherlands, China and United States. Cor Lieftink's co-authors include René Bernards, Roderick L. Beijersbergen, Cun Wang, Bastiaan Evers, Alberto Bardelli, Sara Mainardi, Liqin Wang, Astrid Bosma, Wenxin Qin and Haojie Jin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Medicine.

In The Last Decade

Cor Lieftink

47 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cor Lieftink Netherlands 21 1.2k 484 318 237 217 48 1.7k
Sébastien Jeay Switzerland 24 1.1k 0.9× 631 1.3× 320 1.0× 166 0.7× 176 0.8× 46 1.8k
Josh Lauring United States 22 1.4k 1.1× 515 1.1× 510 1.6× 247 1.0× 272 1.3× 42 2.0k
Peter Horak Germany 20 1.2k 1.0× 457 0.9× 590 1.9× 235 1.0× 242 1.1× 68 1.9k
William Senapedis United States 29 1.6k 1.3× 661 1.4× 202 0.6× 107 0.5× 193 0.9× 79 2.1k
Erika von Euw United States 18 893 0.7× 757 1.6× 209 0.7× 353 1.5× 269 1.2× 30 1.6k
Cheryl M. Koh United States 18 1.6k 1.3× 583 1.2× 569 1.8× 129 0.5× 383 1.8× 26 2.3k
Amir Sonnenblick Israel 22 743 0.6× 885 1.8× 450 1.4× 234 1.0× 212 1.0× 92 1.6k
Simonetta Buglioni Italy 22 930 0.7× 772 1.6× 511 1.6× 188 0.8× 227 1.0× 71 1.7k
Ashish Juvekar United States 11 804 0.6× 468 1.0× 316 1.0× 184 0.8× 131 0.6× 22 1.3k
Esther Bridges United Kingdom 21 1.1k 0.9× 430 0.9× 744 2.3× 190 0.8× 130 0.6× 38 1.7k

Countries citing papers authored by Cor Lieftink

Since Specialization
Citations

This map shows the geographic impact of Cor Lieftink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cor Lieftink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cor Lieftink more than expected).

Fields of papers citing papers by Cor Lieftink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cor Lieftink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cor Lieftink. The network helps show where Cor Lieftink may publish in the future.

Co-authorship network of co-authors of Cor Lieftink

This figure shows the co-authorship network connecting the top 25 collaborators of Cor Lieftink. A scholar is included among the top collaborators of Cor Lieftink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cor Lieftink. Cor Lieftink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drakaki, Alexandra, Natalie Proost, Cor Lieftink, et al.. (2024). ADARp150 counteracts whole genome duplication. Nucleic Acids Research. 52(17). 10370–10384. 1 indexed citations
2.
Burdová, Kamila, Diego Dibitetto, Cor Lieftink, et al.. (2024). PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair. The EMBO Journal. 43(6). 1015–1042. 14 indexed citations
3.
Hoefsmit, Esmée P., Disha Rao, Petros Dimitriadis, et al.. (2023). Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells. Cancer Immunology Research. 11(4). 450–465. 10 indexed citations
4.
Pilzecker, Bas, Aldo Spanjaard, Stefan Preković, et al.. (2023). Mammalian life depends on two distinct pathways of DNA damage tolerance. Proceedings of the National Academy of Sciences. 120(4). e2216055120–e2216055120. 4 indexed citations
5.
Mayayo‐Peralta, Isabel, Karianne Schuurman, Selçuk Yavuz, et al.. (2023). PAXIP1 and STAG2 converge to maintain 3D genome architecture and facilitate promoter/enhancer contacts to enable stress hormone-dependent transcription. Nucleic Acids Research. 51(18). 9576–9593. 10 indexed citations
6.
Buikhuisen, Joyce Y., Kate Cameron, Saskia J.E. Suijkerbuijk, et al.. (2023). Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 56–56. 4 indexed citations
7.
Mulero‐Sánchez, Antonio, Christel Ramirez, Aimée du Chatinier, et al.. (2023). Rational combination of SHP2 and mTOR inhibition for the treatment of hepatocellular carcinoma. Molecular Oncology. 17(6). 964–980. 11 indexed citations
8.
Kruijsbergen, Ila van, Chitvan Mittal, Cor Lieftink, et al.. (2023). Locus-specific proteome decoding reveals Fpt1 as a chromatin-associated negative regulator of RNA polymerase III assembly. Molecular Cell. 83(23). 4205–4221.e9. 4 indexed citations
9.
Fernández, Marta Llauradó, E. Marielle Hijmans, Annemiek M.C. Gennissen, et al.. (2022). NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition. Molecular Cancer Therapeutics. 21(12). 1862–1874. 9 indexed citations
10.
Pogacar, Ziva, Jackie Johnson, Lenno Krenning, et al.. (2022). Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity. PLoS ONE. 17(9). e0273182–e0273182. 12 indexed citations
11.
Pogacar, Ziva, Fleur Jochems, Antonio Mulero‐Sánchez, et al.. (2022). Genetic and compound screens uncover factors modulating cancer cell response to indisulam. Life Science Alliance. 5(9). e202101348–e202101348. 8 indexed citations
12.
Schepers, Arnout, Fleur Jochems, Cor Lieftink, et al.. (2021). Identification of Autophagy-Related Genes as Targets for Senescence Induction Using a Customizable CRISPR-Based Suicide Switch Screen. Molecular Cancer Research. 19(10). 1613–1621. 5 indexed citations
13.
Brunen, Diede, et al.. (2018). PIM Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma. Molecular Cancer Therapeutics. 17(4). 849–857. 27 indexed citations
14.
Berns, Katrien, Joseph J. Caumanns, E. Marielle Hijmans, et al.. (2018). ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors. Oncogene. 37(33). 4611–4625. 77 indexed citations
15.
Wang, Cun, Haojie Jin, Dongmei Gao, et al.. (2018). Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer. Journal of Hepatology. 69(5). 1057–1065. 73 indexed citations
16.
Brunen, Diede, Pauline M.W. van Kempen, Rob Noorlag, et al.. (2016). FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 22(15). 3884–3893. 69 indexed citations
17.
Heynen, Guus J.J.E., Ekaterina Nevedomskaya, Cor Lieftink, et al.. (2016). Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma. Molecular Cancer Research. 14(5). 411–422. 15 indexed citations
18.
Lint, Klaas de, Jos B. Poell, Katarzyna Jastrzebski, et al.. (2016). Sensitizing Triple-Negative Breast Cancer to PI3K Inhibition by Cotargeting IGF1R. Molecular Cancer Therapeutics. 15(7). 1545–1556. 33 indexed citations
19.
Heesbeen, Roy G. H. P. van, Jonne A. Raaijmakers, Marvin E. Tanenbaum, et al.. (2016). Aurora A, MCAK, and Kif18b promote Eg5-independent spindle formation. Chromosoma. 126(4). 473–486. 30 indexed citations
20.
Lamba, Simona, Mariangela Russo, Chong Sun, et al.. (2014). RAF Suppression Synergizes with MEK Inhibition in KRAS Mutant Cancer Cells. Cell Reports. 8(5). 1475–1483. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sébastien Jeay Breakdown of academic impact, for papers by Josh Lauring Breakdown of academic impact, for papers by Peter Horak Breakdown of academic impact, for papers by William Senapedis Breakdown of academic impact, for papers by Erika von Euw Breakdown of academic impact, for papers by Cheryl M. Koh Breakdown of academic impact, for papers by Amir Sonnenblick Breakdown of academic impact, for papers by Simonetta Buglioni Breakdown of academic impact, for papers by Ashish Juvekar Breakdown of academic impact, for papers by Esther Bridges
Rankless by CCL
2026